Fig. 7: Molecular pathways and immune landscape differences between the C1 and C2 EMT–NM subgroups. | npj Precision Oncology

Fig. 7: Molecular pathways and immune landscape differences between the C1 and C2 EMT–NM subgroups.

From: Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer

Fig. 7: Molecular pathways and immune landscape differences between the C1 and C2 EMT–NM subgroups.

A Volcano map illustration between C1 and C2. B GSEA analysis between C1 and C2. C Clinical information difference between C1 and C2. D immune checkpoint comparison between C1 and C2. E Immune infiltration difference between C1 and C2. F Tumor stemness between C1 and C2. G TIDE difference between C1 and C2. Abbreviations: EMT, epithelial–mesenchymal transition; NM, nucleotide metabolism; GSEA, gene set enrichment analysis; TIDE, Tumor Immune Dysfunction and Exclusion.

Back to article page